The neurokinin-1 receptor antagonist aprepitant, a new drug for the treatment of hematological malignancies: Focus on acute myeloid leukemia

  1. Muñoz, M.
  2. Coveñas, R.
Journal:
Journal of Clinical Medicine

ISSN: 2077-0383

Year of publication: 2020

Volume: 9

Issue: 6

Type: Review

DOI: 10.3390/JCM9061659 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus